Delmar, NY, United States of America

Dennis L Edie

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Telik, Inc., Basf Corporation. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis L Edie. Retrieved from https://idiyas.com/inventor/dennis-l-edie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: An Overview of Inventor Dennis L. Edie from Delmar, NY

Introduction

Dennis L. Edie is a notable inventor based in Delmar, NY. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential anticancer properties. With a total of three patents to his name, Edie's work has the potential to impact cancer treatment methodologies and provide new therapeutic options.

Latest Patents

Among his recent innovations, Edie developed a patent for a process and intermediates in the preparation of canfosfamide and its salts. This invention focuses on a method that allows for the synthesis of canfosfamide, with certain intermediates exhibiting anticancer activity. This dual approach not only enhances the efficiency of producing the drug but also contributes valuable compounds to the field of oncology.

Career Highlights

Throughout his career, Dennis L. Edie has worked with esteemed companies known for their contributions to science and technology. He has held positions at Telik, Inc. and BASF Corporation, where he applied his expertise in chemical processes and innovation. His professional journey reflects a commitment to advancing pharmaceutical science.

Collaborations

In his career, Edie has collaborated with prominent professionals in the field. Notable colleagues include William Allen Boulanger and Ronan Y. Guevel. These collaborations have likely enriched his research, allowing for the exchange of ideas and fostering innovation in his projects.

Conclusion

Dennis L. Edie's contributions to the field of pharmaceuticals are noteworthy. His innovative approach to developing processes for anticancer compounds highlights the importance of research and collaboration in advancing healthcare solutions. As he continues his work, he remains a significant figure in the landscape of inventors dedicated to improving the lives of those affected by cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…